The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2018
Price : $35 *
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; HIV infections
- Focus Therapeutic Use
- 03 Oct 2018 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 17 Jun 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.